Why the Ecofibre (ASX:EOF) share price is surging 30% higher this week

The hemp company's shares have been on fire lately…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ecofibre Ltd (ASX: EOF) share price has continued its impressive run today following an interim sales update.

During early afternoon trade, the hemp company's shares are fetching for $1.15, up 6.98%. This brings Ecofibre shares to a gain of around 30% over the last 4 trading days.

A drawing of a rocket follows a chart up, indicating share price lift

Image source: Getty Images

How is Ecofibre performing?

Investors are snapping up Ecofibre shares in light of the company's impressive sales figures for its Ananda Professional business.

Ecofibre's Ananda Health division is the number one provider of hemp-derived CBD for retail pharmacies in the United States. The business produces nutraceutical products, topical creams and ointments. There is even a CBD oil specifically for pets such as dogs and cats.

In its announcement, Ecofibre advised that its Ananda Professional CBD products have recorded their highest revenues since September 2020. The strong result has seen the business achieved sales of around $800,000 for the month of May. September 2020 sales attained roughly $900,000.

Management noted that while the sales rebound is positive, monthly results may fluctuate in the short term.

Ecofibre CEO, Eric Wang touched on the company's progress saying:

This result reflects a combination of trading conditions improving in our core independent pharmacy channel, ongoing investment in new products and direct engagement to support our pharmacy partners.

As we enter a post-COVID environment, we are beginning to see many of our pharmacy partners begin to return to normal operations. Whilst there is still a lot of focus on COVID related activities such as vaccines, it is pleasing to see signs of recovery in our core channel.

Additionally, sales of the new Ananda Professional Chewable products and Women's Health range have been encouraging. We also launched Ananda Professional's new direct-to- consumer e-commerce portal with 70 pharmacies in early May, and the business is now focused on building momentum through positive early-adopter experiences.

Ecofibre share price snapshot

While today's update has lifted Ecofibre shares even further, yearly share price performance has not been so kind to investors. The company's share price has fallen more than 50% from the past 12 months and is down almost 40% year-to-date.

Ecofibre has a market capitalisation of approximately $397 million, with approximately 341 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A man sits nervously at his computer with his mouth resting against his hands clasped in front of him as he stares at the screen of his computer on a home desk.
Healthcare Shares

EBOS Group trims FY26 earnings guidance as fuel costs bite

EBOS Group trims FY26 earnings guidance as elevated fuel costs weigh on its healthcare distribution businesses.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX biotech stock could more than double Canaccord Genuity says

This company has more than one iron in the fire.

Read more »

A medical researcher wearing a white coat sits at her desk in a laboratory conducting a test.
Healthcare Shares

This ASX biotech's shares just hit a new 12-month high, up more than 700% over a year. Here's why

Good news has this company's shares on the up.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Share Market News

Up 68% from a multi-year low. Are Telix shares a buy, sell or hold?

Telix shares crashed to just $8.63 per share in mid-February.

Read more »

Health professional working on his laptop.
Broker Notes

Are Orthocell shares a buy after crashing 7% yesterday?

These healthcare shares could be on discount right now.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

2 ASX healthcare shares I think can beat the market

Healthcare trends like ageing populations and rising demand can create long-term opportunities.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

Up 2,000% in a year, why this ASX healthcare stock is in focus today

4DMedical shares rise as multiple updates land across key markets.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Orthocell caps 26% surge this week with first US Military Surgery

The company's commercial rollout is off to a good start.

Read more »